PHARMAPACE
Mark Identification

PHARMAPACE

Serial Number

86292698

Filing Date

May 27, 2014

Registration Date

Jan 6, 2015

Trademark by

PHARMAPACE INC.

Active Trademark

Classification Information

Business advisory services in the field of medical and clinical safety; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Business management and consultation in the field of clinical trials; Business management consultation in the field of regulatory submissions; Business management consulting and advisory services for the biotechnology and pharmaceutical industry; Business management consulting services in the field of drug development; Business management consulting, strategic planning and business advisory services provided to companies developing new drugs or medical devices or companies conducting clinical trials; Collection and analysis of quality metric data for clinical trial analysis for business purposes; Compilation of statistics; Compiling and analyzing statistics, data and other sources of information for business purposes; Offering business management assistance in the establishment and/or operation of clinical trials; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Providing statistical information; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Statistical analysis and reporting services for business purposes

Advertising and Business